Loading the map…
Other human health activities · London
MRXL
MRXL Limited
Private limited company registered in London, classed under “Other human health activities”.
Headline figures
FY to Aug 2024 · Company only
Turnover
For subscribers
Profit after tax
−£3.67k
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
2 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2024 |
|---|---|
| Profit after tax | −£3.67k |
| Turnover | |
| Net assets | |
| Cash | |
| Employees | |
| Retained reserves |
Every figure for the year
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2024 |
|---|---|
| Fixed assets | |
| Current assets | |
| of which debtors | |
| of which cash | |
| Creditors due within a year | |
| Net current assets | |
| Net assets | |
| Ratios | |
| Current ratioCurrent assets for every £1 owed within a year | |
| Cash ratioCash for every £1 owed within a year | |
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | |
7 balance-sheet lines and 3 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does MRXL do?
Private limited company registered in London, classed under “Other human health activities”.
›How much turnover does MRXL make?
Answered in the full report
›Is MRXL profitable?
No: it made a loss after tax of £3.67k in the year to 31 August 2024, its latest filed accounts.
›How many people work at MRXL?
Answered in the full report
›Where is MRXL based?
Its registered office is 32 Grosvenor Square, London, W1K 2HJ, in London.
›When was MRXL founded?
MRXL Limited was incorporated on 1 August 2023.
›Is MRXL still trading?
The register lists MRXL Limited as active.